4D Molecular Therapeutics, Inc. (FDMT)
USD 3.3
(-3.65%)
USD 3.3
(-3.65%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -75.79 Million | -86.68 Million | -69.13 Million | -50.9 Million | -36.71 Million | -16.25 Million |
| Net Income | -100.83 Million | -107.49 Million | -71.31 Million | -56.69 Million | -49.3 Million | -9.55 Million |
| Depreciation & Amortization | 5.74 Million | 3.88 Million | 3.02 Million | 1.44 Million | 1 Million | 697 Thousand |
| Deferred income taxes | -896 Thousand | - | - | 20 Thousand | 2.65 Million | - |
| Stock-based compensation | 19.66 Million | 17.12 Million | 13.79 Million | 4.98 Million | 3.54 Million | 1.37 Million |
| Change in working capital | 630 Thousand | -1.33 Million | -15.53 Million | -711 Thousand | 259 Thousand | -8.77 Million |
| Other non-cash items | -103 Thousand | 1.14 Million | 898 Thousand | 48 Thousand | 5.13 Million | 2000.00 |
| Investing Cash Flow | 115.71 Million | -17.05 Million | -172.68 Million | -1 Million | -3.2 Million | -414 Thousand |
| Investments in PPE | -2.77 Million | -11.53 Million | -9.11 Million | -1 Million | -3.2 Million | -414 Thousand |
| Acquisitions | 2.77 Million | 11.53 Million | 9.11 Million | - | - | - |
| Investment purchases | -54.8 Million | -153.31 Million | -168.57 Million | - | - | - |
| Sales/Maturities of investments | 173.29 Million | 147.79 Million | 5 Million | - | - | - |
| Other Investing Activities | -2.77 Million | -11.53 Million | -9.11 Million | -1 Million | - | - |
| Financing Cash Flow | 156.83 Million | 3.08 Million | 118.08 Million | 278.98 Million | -2.19 Million | 84.57 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -278.12 Million | -2.27 Million | - |
| Common Stock Issuance | 156.83 Million | 2.73 Million | 114.29 Million | 205.65 Million | 75 Thousand | 105 Thousand |
| Other Financing Activities | 27.62 Million | 355 Thousand | 3.79 Million | 351.45 Million | -2.27 Million | 84.47 Million |
| Accounts receivables | - | 47 Thousand | 1.43 Million | -508 Thousand | 146 Thousand | -803 Thousand |
| Accounts payables | 896 Thousand | -1.63 Million | 2.28 Million | 43 Thousand | 533 Thousand | 438 Thousand |
| Inventory | - | - | -4.53 Million | -591 Thousand | 2.92 Million | 175 Thousand |
| Other working capital | -266 Thousand | 255 Thousand | -14.72 Million | 345 Thousand | -3.34 Million | -8.58 Million |
| Cash at beginning of period | 52.35 Million | 153 Million | 276.72 Million | 49.65 Million | 91.76 Million | 23.85 Million |
| Cash at end of period | 249.1 Million | 52.35 Million | 153 Million | 276.72 Million | 49.65 Million | 91.76 Million |
| Capital Expenditure | -2.77 Million | -11.53 Million | -9.11 Million | -1 Million | -3.2 Million | -414 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 196.75 Million | -100.65 Million | -123.72 Million | 227.07 Million | -42.1 Million | 67.91 Million |
| Free Cash Flow | -78.56 Million | -98.22 Million | -78.24 Million | -51.9 Million | -39.91 Million | -16.66 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -34.95 Million | -32.4 Million | -32.28 Million | -100.83 Million | -10.25 Million | -29.61 Million |
| Depreciation & Amortization | 1.62 Million | 1.59 Million | 1.51 Million | 5.74 Million | 1.39 Million | 1.42 Million |
| Deferred income taxes | - | - | -630 Thousand | -896 Thousand | - | - |
| Stock-based compensation | 6.07 Million | 5.97 Million | 5.91 Million | 19.66 Million | 4.56 Million | 4.96 Million |
| Change in working capital | -688 Thousand | -3.52 Million | 664 Thousand | 630 Thousand | 3.09 Million | 1.35 Million |
| Other non-cash items | 7.8 Million | 7.72 Million | 173 Thousand | -103 Thousand | 29 Thousand | -205 Thousand |
| Investing Cash Flow | -73.53 Million | -263.25 Million | -6.68 Million | 115.71 Million | 29.98 Million | 49.28 Million |
| Investments in PPE | -349 Thousand | -710 Thousand | -549 Thousand | -2.77 Million | -405 Thousand | -805 Thousand |
| Acquisitions | - | - | 49.08 Million | 2.77 Million | - | -50.09 Million |
| Investment purchases | -96.76 Million | -277.32 Million | -34.64 Million | -54.8 Million | - | -5.42 Million |
| Sales/Maturities of investments | 23.57 Million | 14.77 Million | 28.51 Million | 173.29 Million | 30.38 Million | 55.52 Million |
| Other Investing Activities | -73.19 Million | -710 Thousand | -49.08 Million | -2.77 Million | 30.38 Million | 50.09 Million |
| Financing Cash Flow | 17.24 Million | 318.83 Million | 4.76 Million | 156.83 Million | 10.55 Million | 130.51 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 17.24 Million | 318.83 Million | 1000.00 | 156.83 Million | 8.97 Million | 129.72 Million |
| Other Financing Activities | 17.24 Million | 3.11 Million | 4.76 Million | 27.62 Million | 1.58 Million | 799 Thousand |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -786 Thousand | 703 Thousand | -1.08 Million | 896 Thousand | 1.37 Million | 947 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | 98 Thousand | -4.22 Million | 1.75 Million | -266 Thousand | 1.72 Million | 412 Thousand |
| Cash at beginning of period | 275.59 Million | 275.67 Million | 275.67 Million | 52.35 Million | 236.31 Million | 78.56 Million |
| Cash at end of period | 189.06 Million | 275.59 Million | 249.1 Million | 249.1 Million | 275.67 Million | 236.31 Million |
| Capital Expenditure | -349 Thousand | -710 Thousand | -549 Thousand | -2.77 Million | -405 Thousand | -805 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -86.53 Million | -84 Thousand | -26.57 Million | 196.75 Million | 39.36 Million | 157.74 Million |
| Free Cash Flow | -30.59 Million | -29.79 Million | -25.19 Million | -78.56 Million | -1.57 Million | -22.87 Million |
CLSC3
GUJGASLTD
BMO
NRXPW
PAA
3727